316 related articles for article (PubMed ID: 38614123)
1. Lipid regulation of the glucagon receptor family.
Oqua AI; Manchanda Y; McGlone ER; Jones B; Rouse S; Tomas A
J Endocrinol; 2024 Jun; 261(3):. PubMed ID: 38614123
[TBL] [Abstract][Full Text] [Related]
2. Central administration of coagonist of GLP-1 and glucagon receptors improves dyslipidemia.
Patel V; Joharapurkar A; Kshirsagar S; Sutariya B; Patel M; Patel H; Pandey D; Patel D; Bahekar R; Jain M
Biomed Pharmacother; 2018 Feb; 98():364-371. PubMed ID: 29275178
[TBL] [Abstract][Full Text] [Related]
3. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
Roed SN; Nøhr AC; Wismann P; Iversen H; Bräuner-Osborne H; Knudsen SM; Waldhoer M
J Biol Chem; 2015 Jan; 290(2):1233-43. PubMed ID: 25451942
[TBL] [Abstract][Full Text] [Related]
4. Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation.
Schelshorn D; Joly F; Mutel S; Hampe C; Breton B; Mutel V; Lütjens R
Mol Pharmacol; 2012 Mar; 81(3):309-18. PubMed ID: 22108912
[TBL] [Abstract][Full Text] [Related]
5. A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis.
Hu YW; Yang JY; Ma X; Chen ZP; Hu YR; Zhao JY; Li SF; Qiu YR; Lu JB; Wang YC; Gao JJ; Sha YH; Zheng L; Wang Q
J Lipid Res; 2014 Apr; 55(4):681-97. PubMed ID: 24493833
[TBL] [Abstract][Full Text] [Related]
6. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
[TBL] [Abstract][Full Text] [Related]
7. Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.
Estall JL; Yusta B; Drucker DJ
Mol Biol Cell; 2004 Aug; 15(8):3673-87. PubMed ID: 15169869
[TBL] [Abstract][Full Text] [Related]
8. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for
Wang H; Hu W; Liu D; Wüthrich K
FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025
[TBL] [Abstract][Full Text] [Related]
9. Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition.
Patel V; Joharapurkar A; Kshirsagar S; Sutariya B; Patel M; Pandey D; Patel H; Ranvir R; Kadam S; Patel D; Bahekar R; Jain M
Chem Biol Interact; 2018 Feb; 282():13-21. PubMed ID: 29325849
[TBL] [Abstract][Full Text] [Related]
10. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
Estall JL; Koehler JA; Yusta B; Drucker DJ
J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
[TBL] [Abstract][Full Text] [Related]
11. The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice.
Hsieh J; Longuet C; Baker CL; Qin B; Federico LM; Drucker DJ; Adeli K
Diabetologia; 2010 Mar; 53(3):552-61. PubMed ID: 19957161
[TBL] [Abstract][Full Text] [Related]
12. Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats.
Decara J; Rivera P; Arrabal S; Vargas A; Serrano A; Pavón FJ; Dieguez C; Nogueiras R; Rodríguez de Fonseca F; Suárez J
Acta Physiol (Oxf); 2018 Apr; 222(4):e13008. PubMed ID: 29193738
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling.
Cheng YH; Ho MS; Huang WT; Chou YT; King K
J Biol Chem; 2015 Jun; 290(23):14302-13. PubMed ID: 25903129
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors.
Darbalaei S; Yuliantie E; Dai A; Chang R; Zhao P; Yang D; Wang MW; Sexton PM; Wootten D
Biochem Pharmacol; 2020 Oct; 180():114150. PubMed ID: 32682761
[TBL] [Abstract][Full Text] [Related]
15. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors.
Brubaker PL; Drucker DJ
Recept Channels; 2002; 8(3-4):179-88. PubMed ID: 12529935
[TBL] [Abstract][Full Text] [Related]
16. Uncovering the intimate relationship between lipids, cholesterol and GPCR activation.
Oates J; Watts A
Curr Opin Struct Biol; 2011 Dec; 21(6):802-7. PubMed ID: 22036833
[TBL] [Abstract][Full Text] [Related]
17. Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity.
Nogueiras R; Pérez-Tilve D; Veyrat-Durebex C; Morgan DA; Varela L; Haynes WG; Patterson JT; Disse E; Pfluger PT; López M; Woods SC; DiMarchi R; Diéguez C; Rahmouni K; Rohner-Jeanrenaud F; Tschöp MH
J Neurosci; 2009 May; 29(18):5916-25. PubMed ID: 19420258
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of glucagon receptor signaling.
Unson CG
Biopolymers; 2002; 66(4):218-35. PubMed ID: 12491536
[TBL] [Abstract][Full Text] [Related]
19. Agonist-activated glucagon receptors are deubiquitinated at early endosomes by two distinct deubiquitinases to facilitate Rab4a-dependent recycling.
Kaur S; Chen Y; Shenoy SK
J Biol Chem; 2020 Dec; 295(49):16630-16642. PubMed ID: 32967969
[TBL] [Abstract][Full Text] [Related]
20. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.
Al-Zamel N; Al-Sabah S; Luqmani Y; Adi L; Chacko S; Schneider TD; Krasel C
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
